Joseph Gulfo

Anthra Pharmaceuticals, Inc. operates Anthra, an AI-powered integrated platform that assists authors in creating fully finished books by combining manuscript writing, original illustration, and studio-quality narration. The platform guides users through a six-step process, including idea and character description, planning with tools such as beat sheets and mood boards, AI-assisted drafting and editing, consistent artwork creation, and lifelike audiobook narration. Anthra supports exporting books in multiple formats, including epub, pdf, docx, m4b audiobooks, and print-on-demand paperbacks, while allowing authors to retain creative control and ownership. Features include character and world memory for consistent storytelling, prose analysis, sensitivity and continuity checks, and a toolkit accessible via REST and MCP APIs for integration and automation. The platform uses a credit-based pricing model, enabling users to pay only for the services they use. Authors can publish and sell their works through Anthra’s marketplace or embed readers on their own sites, supporting novelists, educators, memoirists, poets, and small publishers in producing, illustrating, narrating, and distributing AI-enhanced books.

Manufactures dermatology treatment products

Functions as a College/University

Develops immunotherapeutic products and vaccines for the treatment of cancer diseases

Functions as a College/University

Operates as an oncology-based pharmaceutical company

Provides life sciences research and medical device technologies

Operates as a blank check company